Non-selective cation channel-mediated Ca 2+ -entry and activation of Ca 2+ /calmodulin-dependent kinase II contribute to G 2 /M cell cycle arrest and survival of irradiated leukemia cells

Cellular Physiology and Biochemistry

Volumn 26, Issue 4-5, 2010, Pages 597-608

  Heise, Nicole ^a   Palme, Daniela ^a   Misovic, Milan ^a,b   Koka, Saisudha ^a   Rudner, Justine ^a   Lang, Florian ^a   Salih, Helmut R ^a   Huber, Stephan M ^a   Henke, Guido ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Calcium Signaling; Calcium Calmodulin Dependent Kinase II; Ionizing Radiation; Patch Clamp Recording; Vanilloid Transient Receptor Potential

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL; CALCIUM ION; CATION CHANNEL; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE PROGRESSION; CELL MEMBRANE CONDUCTANCE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; CLONOGENIC ASSAY; COMPETITIVE INHIBITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME ACTIVITY; ERYTHROID CELL; ERYTHROLEUKEMIA CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IONIZING RADIATION; IRRADIATION; MOLECULAR IMAGING; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN FUNCTION; RADIATION DOSE; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WHOLE CELL;

EID: 78149460344     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322327     Document Type: Article

References (59)

1. Steinhardt RA, Alderton J: Intracellular free calcium rise triggers nuclear envelope breakdown in the sea urchin embryo. Nature 1988;332:364-366.
2. Taylor JT, Zeng XB, Pottle JE, Lee K, Wang AR, Yi SG, Scruggs JA, Sikka SS, Li M: Calcium signaling and T-type calcium channels in cancer cell cycling. World J Gastroenterol 2008;14:4984-4991.
3. Roderick HL, Cook SJ: Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival. Nat Rev Cancer 2008;8:361-375.
4. Lehen'kyi V, Flourakis M, Skryma R, Prevarskaya N: TRPV6 channel controls prostate cancer cell proliferation via Ca(2+)/NFAT-dependent pathways. Oncogene 2007;26:7380-7385.
5. Bolanz KA, Hediger MA, Landowski CP: The role of TRPV6 in breast carcinogenesis. Mol Cancer Ther 2008;7:271-279.
6. Si J, Collins SJ: Activated Ca2+/ calmodulin-dependent protein kinase IIgamma is a critical regulator of myeloid leukemia cell proliferation. Cancer Res 2008;68:3733-3742.
7. Semenova SB, Vassilieva IO, Fomina AF, Runov AL, Negulyaev YA: Endogenous expression of TRPV5 and TRPV6 calcium channels in human leukemia K562 cells. Am J Physiol Cell Physiol 2009;296:C1098-1104.
8. Aguilera DG, Tsimberidou AM: Dasatinib in chronic myeloid leukemia: a review. Ther Clin Risk Manag 2009;5:281-289.
9. Bornhauser M, Kroger N, Schwerdtfeger R, Schafer-Eckart K, Sayer H G, Scheid C, Stelljes M, Kienast J, Mundhenk P, Fruehauf S, Kiehl MG, Wandt H, Theuser C, Ehninger G, Zander AR: Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study. Eur J Haematol 2006;76:9-17.
10. Heinzelmann F, Ottinger H, Muller CH, Allgaier S, Faul C, Bamberg M, Belka C: Total-body irradiation-role and indications: results from the German Registry for Stem Cell Transplantation (DRST). Strahlenther Onkol 2006;182:222-230.
11. Robin M, Guardiola P, Devergie A, Yeshurun M, Shapiro S, Esperou H, Ribaud P, Rocha V, Gluckman E, Socie G: A 10-year median follow-up study after allogeneic stem cell transplantation for chronic myeloid leukemia in chronic phase from HLA-identical sibling donors. Leukemia 2005;19:1613-1620.
12. Uberti JP, Agovi MA, Tarima S, Haagenson M, Gandham S, Anasetti C, Baker KS, Bolwell BJ, Bornhauser M, Chan KW, Copelan E, Davies SM, Finke J, Hale GA, Kollman C, McCarthy PL, Ratanatharathorn V, Ringden O, Weisdorf DJ, Rizzo JD: Comparative analysis of BU and CY versus CY and TBI in full intensity unrelated marrow donor transplantation for AML, CML and myelodysplasia. Bone Marrow Transplant 2010, in press.
13. Weisser M, Schleuning M, Ledderose G, Rolf B, Schnittger S, Schoch C, Schwerdtfeger R, Kolb HJ: Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease. Bone Marrow Transplant 2004;34:1083-1088.
14. Lozzio CB, Lozzio BB: Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 1975;45:321-334.
15. Barry PH, Lynch JW: Liquid junction potentials and small cell effects in patch-clamp analysis. J Membr Biol 1991;121:101-117.
16. Assef YA, Damiano AE, Zotta E, Ibarra C, Kotsias BA: CFTR in K562 human leukemic cells. Am J Physiol Cell Physiol 2003;285:C480-488.
17. Kasinathan RS, Foller M, Lang C, Koka S, Lang F, Huber SM: Oxidation induces ClC-3-dependent anion channels in human leukaemia cells. FEBS Lett 2007;581:5407-5412.
18. Cavarra MS, del Monaco SM, Assef YA, Ibarra C, Kotsias BA: HERG1 currents in native K562 leukemic cells. J Membr Biol 2007;219:49-61.
19. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM: Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-1560.
20. Foller M, Kasinathan RS, Duranton C, Wieder T, Huber SM, Lang F: PGE2-induced apoptotic cell death in K562 human leukaemia cells. Cell Physiol Biochem 2006;17:201-210.
21. Hoenderop JG, Bindels RJ: Epithelial Ca2+ and Mg2+ channels in health and disease. J Am Soc Nephrol 2005;16:15-26.
22. Semenova SB, Fomina AF, Vassilieva IO, Negulyaev YA: Properties of Mg(2+)-dependent cation channels in human leukemia K562 cells. J Cell Physiol 2005;205:372-378.
23. Iliakis G, Wang Y, Guan J, Wang H: DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 2003;22:5834-5847.
24. Nimbalkar D, Quelle FW: Phosphoinositide 3-kinase signaling overrides a G2 phase arrest checkpoint and promotes aberrant cell cycling and death of hematopoietic cells after DNA damage. Cell Cycle 2008;7:2877-2885.
25. Bohmer C, Palmada M, Kenngott C, Lindner R, Klaus F, Laufer J, Lang F: Regulation of the epithelial calcium channel TRPV6 by the serum and glucocorticoid-inducible kinase isoforms SGK1 and SGK3. FEBS Lett 2007;581:5586-5590.
26. Palmada M, Poppendieck S, Embark HM, Van De Graaf SF, Boehmer C, Bindels RJ, Lang F: Requirement of PDZ domains for the stimulation of the epithelial Ca2+ channel TRPV5 by the NHE regulating factor NHERF2 and the serum and glucocorticoid inducible kinase SGK1. Cell Physiol Biochem 2005;15:175-182.
27. Embark HM, Setiawan I, Poppendieck S, van de Graaf SF, Boehmer C, Palmada M, Wieder T, Gerstberger R, Cohen P, Yun CC, Bindels RJ, Lang F: Regulation of the epithelial Ca2+ channel TRPV5 by the NHE regulating factor NHERF2 and the serum and glucocorticoid inducible kinase isoforms SGK1 and SGK3 expressed in Xenopus oocytes. Cell Physiol Biochem 2004;14:203-212.
28. Nilius B, Owsianik G, Voets T: Transient receptor potential channels meet phosphoinositides. Embo J 2008;27:2809-2816.
29. Hallahan DE, Bleakman D, Virudachalam S, Lee D, Grdina D, Kufe DW, Weichselbaum RR: The role of intracellular calcium in the cellular response to ionizing radiation. Radiat Res 1994;138:392-400.
30. Liu SZ, Su X, Han ZB, Zhang YC, Qi J: Effect of low dose radiation on intracellular calcium and protein kinase C in lymphocytes. Biomed Environ Sci 1994;7:284-291.
31. Todd DG, Mikkelsen RB: Ionizing radiation induces a transient increase in cytosolic free [Ca2+] in human epithelial tumor cells. Cancer Res 1994;54:5224-5230.
32. Kahl CR, Means AR: Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev 2003;24:719-736.
33. Iwasa Y, Iwasa T, Higashi K, Matsui K, Miyamoto E: Modulation by phosphorylation of interaction between calmodulin and histones. FEBS Lett 1981;133:95-98.
34. Smallwood HS, Lopez-Ferrer D, Eberlein PE, Watson DJ, Squier TC: Calmodulin mediates DNA repair pathways involving H2AX in response to low-dose radiation exposure of RAW 264.7 macrophages. Chem Res Toxicol 2009;22:460-470.
35. Wang Y, Mallya SM, Sikpi MO: Calmodulin antagonists and cAMP inhibit ionizing-radiation-enhancement of double-strand-break repair in human cells. Mutat Res 2000;460:29-39.
36. Du YC, Gu S, Zhou J, Wang T, Cai H, Macinnes MA, Bradbury EM, Chen X: The dynamic alterations of H2AX complex during DNA repair detected by a proteomic approach reveal the critical roles of Ca(2+)/calmodulin in the ionizing radiation-induced cell cycle arrest. Mol Cell Proteomics 2006;5:1033-1044.
37. Watson CA, Chang-Liu CM, Woloschak GE: Modulation of calmodulin by UV and X-rays in primary human endothelial cell cultures. Int J Radiat Biol 2000;76:1455-1461.
38. Takuwa N, Zhou W, Takuwa Y: Calcium, calmodulin and cell cycle progression. Cell Signal 1995;7:93-104.
39. Bayer KU, Schulman H: Regulation of signal transduction by protein targeting: the case for CaMKII. Biochem Biophys Res Commun 2001;289:917-923.
40. Bayer KU, De Koninck P, Schulman H: Alternative splicing modulates the frequency-dependent response of CaMKII to Ca(2+) oscillations. Embo J 2002;21:3590-3597.
41. Laabich A, Li G, Cooper NG: Calcium/ calmodulin-dependent protein kinase II containing a nuclear localizing signal is altered in retinal neurons exposed to N-methyl-D-aspartate. Brain Res Mol Brain Res 2000;76:253-265.
42. Rich DP, Schworer CM, Colbran RJ, Soderling TR: Proteolytic activation of calcium/calmodulin-dependent protein kinase II: Putative function in synaptic plasticity. Mol Cell Neurosci 1990;1:107-116.
43. Li N, Wang C, Wu Y, Liu X, Cao X: Ca(2+)/calmodulin-dependent protein kinase II promotes cell cycle progression by directly activating MEK1 and subsequently modulating p27 phosphorylation. J Biol Chem 2009;284:3021-3027.
44. Yuan K, Chung LW, Siegal G P, Zayzafoon M: alpha-CaMKII controls the growth of human osteosarcoma by regulating cell cycle progression. Lab Invest 2007;87:938-950.
45. Glover-Collins K, Thompson ME: Nuclear export of BRCA1 occurs during early S phase and is calcium-dependent. Cell Signal 2008;20:958-968.
46. Torricelli C, Fortino V, Capurro E, Valacchi G, Pacini A, Muscettola M, Soucek K, Maioli E: Rottlerin inhibits the nuclear factor kappaB/cyclin-D1 cascade in MCF-7 breast cancer cells. Life Sci 2008;82:638-643.
47. Wang C, Li N, Liu X, Zheng Y, Cao X: A novel endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest via p27 stabilization. J Biol Chem 2008;283:11565-11574.
48. Ma S, Yang Y, Wang C, Hui N, Gu L, Zhong H, Cai Z, Wang Q, Zhang Q, Li N, Cao X: Endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest and apoptosis through down-regulation of the phosphatidylinositide 3-kinase/Akt/ HDM2 pathway. J Biol Chem 2009;284:24773-24782.
49. Patel R, Holt M, Philipova R, Moss S, Schulman H, Hidaka H, Whitaker M: Calcium/calmodulin-dependent phosphorylation and activation of human Cdc25-C at the G2/M phase transition in HeLa cells. J Biol Chem 1999;274:7958-7968.
50. Soliman EM, Rodrigues MA, Gomes DA, Sheung N, Yu J, Amaya MJ, Nathanson MH, Dranoff JA: Intracellular calcium signals regulate growth of hepatic stellate cells via specific effects on cell cycle progression. Cell Calcium 2009;45:284-292.
51. Matsumoto Y, Maller JL: Calcium, calmodulin, and CaMKII requirement for initiation of centrosome duplication in Xenopus egg extracts. Science 2002;295:499-502.
52. Holmfeldt P, Zhang X, Stenmark S, Walczak CE, Gullberg M: CaMKIIgamma-mediated inactivation of the Kin I kinesin MCAK is essential for bipolar spindle formation. Embo J 2005;24:1256-1266.
53. D'Angiolella V, Palazzo L, Santarpia C, Costanzo V, Grieco D: Role for non-proteolytic control of M-phase promoting factor activity at M-phase exit. PLoS ONE 2007;2:e247.
54. Hutchins JR, Dikovskaya D, Clarke PR: Regulation of Cdc2/cyclin B activation in Xenopus egg extracts via inhibitory phosphorylation of Cdc25C phosphatase by Ca(2+)/calmodulin-dependent protein [corrected] kinase II. Mol Biol Cell 2003;14:4003-4014.
55. Duan S, Yao Z, Hou D, Wu Z, Zhu WG, Wu M: Phosphorylation of Pirh2 by calmodulin-dependent kinase II impairs its ability to ubiquitinate p53. Embo J 2007;26:3062-3074.
56. MacDonnell SM, Weisser-Thomas J, Kubo H, Hanscome M, Liu Q, Jaleel N, Berretta R, Chen X, Brown JH, Sabri AK, Molkentin JD, Houser SR: CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes. Circ Res 2009;105:316-325.
57. Planas-Silva MD, Means AR: Expression of a constitutive form of calcium/ calmodulin dependent protein kinase II leads to arrest of the cell cycle in G2. Embo J 1992;11:507-517.
58. Maga G, Mossi R, Fischer R, Berchtold MW, Hubscher U: Phosphorylation of the PCNA binding domain of the large subunit of replication factor C by Ca2+/ calmodulin-dependent protein kinase II inhibits DNA synthesis. Biochemistry 1997;36:5300-5310.
59. Enns L, Murray D, Mirzayans R: Effects of the protein kinase inhibitors wortmannin and KN62 on cellular radiosensitivity and radiation-activated S phase and G1/S checkpoints in normal human fibroblasts. Br J Cancer 1999;81:959-965.